Last reviewed · How we verify
NCT05904847
The Effect of Theory-Based Education on Patient Empowerment and Self-Efficacy in Patients With Type 2 Diabetes
NA trial testing Application of The Theory of Planned Behaviour for Diabetes in Diabete Type 2 in 98 participants. Completed in 26 October 2023.
17 June 2023
Quick facts
| Lead sponsor | Sakarya University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | other |
| Enrollment | 98 |
| Start date | 16 April 2023 |
| Primary completion | 17 June 2023 |
| Estimated completion | 26 October 2023 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Application of The Theory of Planned Behaviour for Diabetes
Conditions studied
- Diabete Type 2 — all drugs for Diabete Type 2 →
Sponsor
Sakarya University
Who can join
Adults 40 to 80, any sex, with Diabete Type 2. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
It is essential to manage the disease to prevent and reduce complications and mortality in patients with diabetes. Adequate information and options should be provided to patients by healthcare providers so that patients can make informed choices. Patient education is a patient empowerment process designed to enable patients to be responsible for their health. With this study, it is considered essential to educate diabetic patients according to the theory of planned behavior and to develop self-efficacy by contributing to patient empowerment in this way.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05904847
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Diabete Type 2
Currently open trials in the same condition.
- NCT07506356 — Investigation of Gastric Emptying by Gastric Ultrasonography in Diabetic Patients Treated With GLP-1 Receptors · recruiting
- NCT07467460 — Precision Medicine and Neurodegenerative Diseases: Advanced Systems for the Diagnosis and Treatment of Parkinson's Disea · recruiting
- NCT07469943 — The Effect of Sodium Glucose Co-trnasportert Type 2 Inhibitors on Arterial Stiffness, Endothelial Glycocalyx Thickness a · recruiting
- NCT07495787 — Magnetic Compression Anastomosis Procedure for Partial Jejunoileal Anastomosis: Assessing the Viability of an Innovative · NA · recruiting
- NCT07212075 — Precision Subclassification of Mental Health in Diabetes: Digital Twins for Precision Mental Health to Track Subgroups · recruiting
Other Sakarya University trials
Trials by the same sponsor.
- NCT07467655 — THE EFFECT OF DIGITAL STORYTELLING ON NURSING STUDENTS' NURSING PROCESS EDUCATION · NA · not yet recruiting
- NCT07508579 — Effect of Hypothermia on BIS and PSI Correlation During Cardiopulmonary Bypass · not yet recruiting
- NCT07537335 — Knee Osteoartritis Genicular Nerve RF Ablation vs Alcohol Neurolysis · NA · not yet recruiting
- NCT07533669 — Effect of a Preoperative Sensory Modulation Room on Pain, Anxiety, and Sleep in Kidney Transplant Patients · NA · not yet recruiting
- NCT07487324 — Oxygenation in Posterior Stabilization Surgery · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05904847 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sakarya University
- Last refreshed: 7 May 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05904847.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing